TheAesthetic Index

Lumenis AcuPulse DUO

CO2 Fractional/Ablative · CO2 10600nm fractional + surgical

Work at Lumenis? — one claim covers all 21 of your devices.
CurrentFDA status under verificationBe the first to review

The Lumenis AcuPulse DUO typically sells new in the $100k–$140k range in the US. Lumenis AcuPulse DUO's FDA status is under verification by our research team. Figures are market estimates verified August 6, 2026.

Last verified: August 6, 2026 · How we verify

New: $100k–$140k|Used: —market estimate, no email required

Key facts
ManufacturerLumenis
CompanyOwner: Baring Private Equity Asia (BPEA, now part of EQT) (private equity owned, since 2019) · Distribution: direct
CategoryResurfacing, Tattoo & Vascular
TechnologyCO2 10600nm fractional + surgical
FDA statusFDA status under verification
New price range$100k–$140k
Used price rangeNot published
ConsumablesNot published
Launch year2021
Last verifiedAugust 6, 2026
Save device

Overview

Updated AcuPulse with surgical delivery options

FDA & regulatory status

FDA status under verificationRegulatory status under verification

FDA status under verification — see our FDA guide. We do not publish an indication or a clearance number for this profile until the record is confirmed against the FDA database.

Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.

Recent industry events

How we source company data

Ownership and corporate changes at Lumenis that can affect warranty, service and parts availability.

  1. Sep 2021

    Boston Scientific acquires Lumenis surgical unit for $1.07B

    Divestiture

    Boston Scientific acquired the Lumenis surgical/urology business for $1.07B upfront, announced March 3, 2021 and closed September 1, 2021. The aesthetics and ophthalmology businesses were retained by Baring Private Equity Asia and operate as Lumenis Be Ltd.

    Source: Boston Scientific and BPEA press releases

Treatment economics

Economics data for this platform hasn't been published yet.

Chains using this device

No confirmed chain deployments recorded yet.

Owner reviews

Write a review

No verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.

Alternatives

DEKA (Cartessa) SmartXide Punto

CO2 Fractional/Ablative · $60k–$90k

ProfileCompare

Lumenis UltraPulse DUO

CO2 Fractional/Ablative

ProfileCompare

DEKA SmartXide2 DOT/RF

CO2 Fractional/Ablative

ProfileCompare

DEKA SmartXide DOT

CO2 Fractional/Ablative

ProfileCompare

History

Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.

  1. August 1, 2026

    Record created

    Added to The Aesthetic Index — August 2026

    Source: The Aesthetic Index editorial

Get the full State of Aesthetic Devices 2026 report

The first full census of the US aesthetic device market — preview it free.

Get the report